Clinical Trial Details
— Status: Active, not recruiting
Administrative data
| NCT number |
NCT05687461 |
| Other study ID # |
12100000400014014Y |
| Secondary ID |
|
| Status |
Active, not recruiting |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
July 1, 2022 |
| Est. completion date |
July 31, 2025 |
Study information
| Verified date |
January 2023 |
| Source |
China-Japan Friendship Hospital |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
1. Build a national diagnosis and treatment quality control platform for major respiratory
diseases It will establish and improved a "National diagnosis and Treatment quality
control Platform for major respiratory diseases", and form a three-level network of
diagnosis and treatment quality control for major respiratory diseases with a
three-level system structure of "national, provincial and hospital".
2. Promote standardized diagnosis and treatment techniques for major respiratory diseases
Relying on the specialized disease collaboration group or innovative unit model,
all-round and hierarchical precision training and teaching are carried out to popularize
and promote standardized diagnosis and treatment technology schemes for major
respiratory diseases, so as to achieve the homogenization of diagnosis and treatment
level for major respiratory diseases.
Description:
1. Build a national diagnosis and treatment quality control platform for major respiratory
diseases Cooperate with the Medical Administration Administration of the National Health
Commission, the Medical Administration Institute of the National Health Commission and
the National Center for Respiratory Disease Medical Quality Control to integrate the
existing diagnosis and treatment quality indicators and data from NCIS (National Medical
Quality Management and Control Information Network) and HQMS (Hospital Quality
Monitoring System), and determine the definition, data sources and collection rules of
core quality control indicators. It has established and improved a "National diagnosis
and Treatment quality control Platform for major respiratory diseases", and formed a
three-level network of diagnosis and treatment quality control for major respiratory
diseases with a three-level system structure of "national, provincial and hospital".
2. To master the incidence trend and diagnosis and treatment quality of major respiratory
diseases Through the big data integration and analysis function of the "National
Diagnosis and Treatment Quality Control Platform for Major Respiratory Diseases", the
incidence trend and law of various major respiratory diseases are mastered. To
understand the difference in the diagnosis and treatment quality of respiratory diseases
in hospitals of different regions and levels, including the allocation of related
resources (such as personnel, technology, equipment, information construction, etc.);
The status of diagnosis and treatment ability (prevention, diagnosis, treatment,
rehabilitation, etc.); Current burden of disease (e.g. morbidity, case fatality rate,
average length of stay, average cost of stay, etc.)
3. Promote standardized diagnosis and treatment techniques for major respiratory diseases
Relying on the specialized disease collaboration group or innovative unit model, through
online and offline academic conferences, continuing medical education, specialized
training, visits and exchanges, case discussions, knowledge competitions, wechat public
accounts and other new media means, regularly focus on "prevention, diagnosis,
treatment, rehabilitation, management, quality control" and many other aspects.
Comprehensive and hierarchical precision training and teaching should be carried out to
popularize and promote standardized diagnosis and treatment technology schemes for major
respiratory diseases, so as to achieve the homogenization of diagnosis and treatment
levels for major respiratory diseases.
